Agreed and I am not surprised given the qualifications of the board - none have experience in medical devices.
Russo (Chairman) comes from Kmart.
Corlett comes from finance.
Gordon comes from furniture retail.
Flitcroft is a career company secretary.
Then you look at the co-CEOs. Blickstead has no experince in the medical devices. Borg on the other hand has had experience earlier in her career but she has been out of the industry for a while.
Is it any surprise that this board wasn't on top of the US reimbursement last year? Or that they weren't on top of the manufacturing this year?
Ann: Trading Halt, page-15
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SOM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.015(3.57%) |
Mkt cap ! $94.00M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 46.5¢ | 42.0¢ | $143.2K | 334.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3550 | 43.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 26291 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| SOM (ASX) Chart |